Asoprisnil
Jump to navigation
Jump to search
Template:Short description Template:Drugbox
Asoprisnil (INN; developmental code name J-867) is a synthetic, steroidal selective progesterone receptor modulator that was under development by Schering and TAP Pharmaceutical Products for the treatment of uterine fibroids.[1] In 2005, phase III clinical trials were discontinued due to endometrial changes in patients.[2]
See also
References
<templatestyles src="Reflist/styles.css" />
- ↑ Script error: No such module "Citation/CS1".
- ↑ Schering Interim Report Q1-3 2005
Script error: No such module "Check for unknown parameters".
Template:Glucocorticoid receptor modulators Template:Progesterone receptor modulators